Asparlas 3,750 unit/5 ML vial 5ML
Ended Awarded
- Contract number
- SPE2DR26FQWB8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $61,097
Award facts
- Contract value 100% obligated
- $61,096.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $61,096.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 3,750 units of Asparlas (5 ML vials). This firm fixed-price delivery order, issued on November 13, 2025, with an ultimate completion date of December 5, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform the work at its headquarters location in Park Ridge, Illinois.
This delivery order operates under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which carries a $499,999,999 ceiling value through December 31, 2036. The PPV-G GEN V represents a critical component of the Department of Defense's broader $30.3 billion pharmaceutical supply strategy, positioning DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply branded and generic prescription drugs, biologics, and medical consumables to military healthcare facilities worldwide. The company's established performance record across numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FQWB8?
SPE2DR26FQWB8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FQWB8 worth?
The government has obligated $61,097 on SPE2DR26FQWB8.
Is contract SPE2DR26FQWB8 an order under another contract?
Yes. SPE2DR26FQWB8 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWB8 competed?
The extent of competition for SPE2DR26FQWB8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award